Jubilant Ingrevia Limited (BOM:543271)

Market Cap	127.57B
Revenue (ttm)	41.78B
Net Income (ttm)	2.51B
Shares Out	n/a
EPS (ttm)	15.84
PE Ratio	50.79
Forward PE	39.20
Dividend	5.00 (0.62%)
Ex-Dividend Date	Jul 25, 2025

Volume	14,019
Average Volume	51,678
Open	815.65
Previous Close	812.95
Day's Range	799.00 - 821.10
52-Week Range	524.30 - 884.95
Beta	n/a
RSI	66.74
Earnings Date	Jul 15, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal...

• Industry: Chemicals and Allied Products
• Founded: 2019
• Employees: 2,283
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543271

Financial Performance

In 2024, Jubilant Ingrevia's revenue was 41.78 billion, an increase of 1.01% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.